Increasing prevalence and incidence of multiple sclerosis in northern Japan

Multiple Sclerosis

Volumn 14, Issue 7, 2008, Pages 887-892

  Houzen, H ^a   Niino, Masaaki ^b   Hata, D ^a   Nakano, F ^a   Kikuchi, S ^c   Fukazawa, T ^d   Sasaki, H ^b  

^a Obihiro Kosei General Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO MEDICAL CENTER   (Japan)

^d Sapporo Neurology Clinic   (Japan)

Author keywords

Epidemiology; Incidence; MRI; Multiple sclerosis; Prevalence; Spinal cord

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASIA; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; JAPAN; MALE; MORBIDITY; MULTIPLE SCLEROSIS; NEUROPATHY; OPTIC NERVE DISEASE; PATIENT ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; SPINAL NERVE; INFORMATION PROCESSING; MIDDLE AGED; PATHOLOGY; SPINAL CORD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; SPINAL CORD;

EID: 54449089887     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508090226     Document Type: Article

References (27)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R,. How common are the "common" neurologic disorders? Neurology 2007; 68: 326-337.
2. Zivadinov R, Iona L, Monti-Bragadin L,. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003; 22: 65-74.
3. Pugliatti M, Riise T, Sotgiu MA,. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 2005; 25: 129-134.
4. Nicoletti A, Patti F, Lo Fermo S,. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005; 65: 1259-1263.
5. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M,. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003; 61: 1373-1377.
6. Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM,. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006; 66: 182-186.
7. Kuroiwa Y, Shibasaki H, Ikeda M,. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology 1983; 2: 62-69.
8. Houzen H, Niino M, Kikuchi S,. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003; 211: 49-53.
9. Cheng Q, Miao L, Zhang J,. A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007; 68: 1495-1500.
10. Lau KK, Wong LK, Li LS, Chan YW, Li HL, Wong V,. Epidemiological study of multiple sclerosis in Hong Kong Chinese: Questionnaire survey. Hong Kong Med J 2002; 8: 77-80.
11. Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE,. Multiple sclerosis in Taiwan. J Chin Med Assoc 2004; 67: 500-505.
12. Itoh T, Aizawa H, Hashimoto K,. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci 2003; 214: 7-9.
13. Polman CH, Reingold SC, Edan G,. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005; 58: 840-846.
14. Kira J,. Epidemiology of multiple sclerosis in Japanese: With special reference to opticospinal multiple sclerosis. Rinsho Shinkeigaku 2006; 46: 859-862.
15. Poser CM, Paty DW, Scheinberg L,. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
16. Fukazawa T, Tashiro K, Hamada T,. Multiple sclerosis in Hokkaido, the northernmost island of Japan: Prospective analyses of clinical features. Intern Med 1992; 31: 349-352.
17. Schoenberg BS,. Calculating confidence interval for rates and ratios. Neuroepidemiology 1983; 2: 257-265.
18. Rosner B,. The rate ratio. In: Fundamentals of biostatistics. 6th ed. Belmont: Thomson Books/Cole; 2006. p. 756-758.
19. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
20. Fleming JO, Cook TD,. Multiple sclerosis and the hygiene hypothesis. Neurology 2006; 67: 2085-2086.
21. Correale J, Farez M,. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007; 61: 97-108.
22. Ascherio A, Munger KL,. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: 288-299.
23. Hernan MA, Jick SS, Olek MJ, Jick H,. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study. Neurology 2004; 63: 838-842.
24. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T,. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 1975; 25: 845-851.
25. Orton SM, Herrera BM, Yee IM,. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932-936.
26. Shibasaki H, Kubo N, Nishitani H, Saida T, Ohno Y, Fukuyama Y,. Nationwide survey of multiple sclerosis in Japan: Reappraisal of clinical features. J Trop Geogr Neurol 1992; 31: 349-352.
27. Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M,. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995; 195: 725-732.